Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark N. Lampert currently holds 3,989,130 shares of FACET BIOTECH CORP (FACT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark N. Lampert has been a net seller of FACT stock. They have purchased $66.1M and sold $80.1M worth of shares.
Mark N. Lampert's most recent insider trade was on Aug 9, 2022, when they sold 3,754,000 shares at $0.00 per share.
Mark N. Lampert serves as Executive at FACET BIOTECH CORP (FACT). They have executed 175 insider transactions totaling $146.2M over their tenure at the company.
Mark N. Lampert holds the position of Executive at FACET BIOTECH CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Mark N. Lampert has shown a selling trading pattern, with $66.1M in total purchases and $80.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark N. Lampert was on Aug 9, 2022, when they sold $23.6M worth of CTIC shares. This transaction involved 3,850,803 shares at $6.12 per share.
Mark N. Lampert currently owns 3,989,130 shares of FACET BIOTECH CORP (FACT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark N. Lampert's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark N. Lampert has 175 Form 4 filings on record as an insider at FACET BIOTECH CORP.
Set alerts for Mark N. Lampert and 40,000+ other insiders.